Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
8.6
252.88%
80%
—
76.62%
Every year
—
5 Years
Score8.6
Net Growth252.88%
Net Trend80%
Net Income Consistency—
Rev Growth76.62%
Rev TrendEvery year
Revenue Consistency—
Boston Scientific Corp fundamental performance
Between 2020 and 2025, revenue grew from $ 9.91B to $ 20.07B and net income went from -$ 82M to $ 2.88B. Revenue increased in every one of those 5 years; net income in 4.
Between 2015 and 2025, revenue grew from $ 7.47B to $ 20.07B and net income went from -$ 239M to $ 2.88B. Revenue increased in 9 of those 10 years; net income in 7.
Boston Scientific Corp currently holds a 20-year HDB Score of 5.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 51.42 | — |
1 Year2025-08-12 | $ 102.64 | -49.90% |
5 Years2021-08-12 | $ 44.07 | 16.68% |
10 Years2016-08-12 | $ 23.89 | 115.24% |
20 Years2006-08-11 | $ 16.30 | 215.46% |
30 Years1996-08-12 | $ 12.16 | 322.99% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 |
|---|---|---|---|---|---|---|
| Price | $ 51.42 | $ 102.64 | $ 44.07 | $ 23.89 | $ 16.30 | $ 12.16 |
| Return | — | -49.90% | 16.68% | 115.24% | 215.46% | 322.99% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 20.99B | $ 3.67B | |
| 2025 | $ 20.07B | $ 2.88B | $ 2.04B |
| 2024 | $ 16.74B | $ 1.85B | $ 414M |
| 2023 | $ 14.24B | $ 1.59B | $ 865M |
| 2022 | $ 12.68B | $ 698M | $ 928M |
| 2021 | $ 11.88B | $ 1.04B | $ 1.92B |
| 2020 | $ 9.91B | -$ 82M | $ 1.73B |
| 2019 | $ 10.73B | $ 4.70B | $ 217M |
| 2018 | $ 9.82B | $ 1.67B | $ 146M |
| 2017 | $ 9.04B | $ 104M | $ 188M |
| 2016 | $ 8.38B | $ 347M | $ 196M |
| 2015 | $ 7.47B | -$ 239M | $ 319M |
| 2014 | $ 7.38B | -$ 119M | $ 587M |
| 2013 | $ 7.14B | -$ 121M | $ 217M |
| 2012 | $ 7.24B | -$ 4.06B | $ 207M |
| 2011 | $ 7.62B | $ 441M | $ 267M |
| 2010 | $ 7.80B | -$ 1.06B | $ 213M |
| 2009 | $ 8.18B | -$ 1.02B | $ 864M |
| 2008 | $ 8.05B | -$ 2.03B | $ 1.64B |
| 2007 | $ 8.35B | -$ 495M | $ 1.45B |
| 2006 | $ 7.82B | -$ 3.57B | $ 1.66B |
| 2005 | $ 6.28B | $ 628M | $ 848M |
| 2004 | $ 5.62B | $ 1.06B | $ 1.64B |
| 2003 | $ 3.47B | $ 472M | $ 671M |
| 2002 | $ 2.91B | $ 373M | $ 277M |
| 2001 | $ 2.67B | -$ 54M | $ 185M |
| 2000 | $ 2.66B | $ 373M | $ 60M |
| 1999 | $ 2.84B | $ 371M | $ 78M |
| 1998 | $ 2.23B | -$ 264M | $ 70M |
| 1997 | $ 1.87B | $ 139M | $ 58M |
| 1996 | $ 1.46B | $ 167M | $ 58M |
| 1995 | $ 1.10B | $ 8M | $ 115M |
| 1994 | $ 448M | $ 79M | $ 90M |
| 1993 | $ 380M | $ 69M | $ 60M |
| IPO1992 | $ 315M | $ 56M | $ 95M |
Explore beyond BSX
You're looking at Boston Scientific Corp. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
